Interestingly, the number of co-occurring genes regulating the EMT and cancer stem cell (CSC) programs correspond to the type of AXL alterations (i.e., high in AXL amplification, low in AXL deletion) at the copy number level (Fig. 5d). The gene discussed is AXL; the disease is cancer.